Literature DB >> 24124163

Association between endogenous sex steroid hormones and inflammatory biomarkers in US men.

K K Tsilidis1, S Rohrmann, K A McGlynn, S J Nyante, D S Lopez, G Bradwin, M Feinleib, C E Joshu, N Kanarek, W G Nelson, E Selvin, E A Platz.   

Abstract

Sex steroid hormones and inflammatory biomarkers are both associated with the development and progression of chronic diseases, but their interrelationship is relatively uncharacterized. We examined the association of sex hormones and sex hormone-binding globulin (SHBG) with biomarkers of inflammation, C-reactive protein (CRP) and white blood cell (WBC) count. The study included data from 809 adult men in the National Health and Nutrition Examination Survey 1999-2004. Geometric means and 95% confidence intervals were estimated separately for CRP and WBC concentrations by sex steroid hormones and SHBG using weighted linear regression models. Higher concentrations of total (slope per one quintile in concentration, -0.18; p-trend, 0.001) and calculated free (slope, -0.13; p-trend, 0.03) testosterone were statistically significantly associated with lower concentrations of CRP, but not with WBC count. Men in the bottom quintile of total testosterone (≤3.3 ng/mL), who might be considered to have clinically low testosterone, were more likely to have elevated CRP (≥3 mg/L) compared with men in the top four quintiles (OR, 1.61; 95% CI, 1.00-2.61). Total and calculated free estradiol (E2) were positively associated with both CRP (Total E2: slope, 0.14; p-trend, <0.001; Free E2: slope, 0.15; p-trend, <0.001) and WBC (Total E2: slope, 0.02; p-trend, 0.08; Free E2: slope, 0.02; p-trend, 0.02) concentrations. SHBG concentrations were inversely associated with WBC count (slope, -0.03; p-trend, 0.04), but not with CRP. These cross-sectional findings are consistent with the hypothesis that higher androgen and lower oestrogen concentrations may have an anti-inflammatory effect in men.
© 2013 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  C-reactive protein; cross-sectional study; estradiol; testosterone; white blood cell

Mesh:

Substances:

Year:  2013        PMID: 24124163      PMCID: PMC3812341          DOI: 10.1111/j.2047-2927.2013.00129.x

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  44 in total

1.  Estradiol and inflammatory markers in older men.

Authors:  Marcello Maggio; Gian Paolo Ceda; Fulvio Lauretani; Stefania Bandinelli; E Jeffrey Metter; Andrea Artoni; Elisa Gatti; Carmelinda Ruggiero; Jack M Guralnik; Giorgio Valenti; Shari M Ling; Shehzad Basaria; Luigi Ferrucci
Journal:  J Clin Endocrinol Metab       Date:  2008-12-02       Impact factor: 5.958

2.  Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.

Authors:  Svetlana Y Kalinchenko; Yuliya A Tishova; George J Mskhalaya; Louis J G Gooren; Erik J Giltay; Farid Saad
Journal:  Clin Endocrinol (Oxf)       Date:  2010-11       Impact factor: 3.478

3.  The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Sabine Rohrmann; Elizabeth A Platz; Elizabeth Selvin; Meredith S Shiels; Corinne E Joshu; Andy Menke; Manning Feinleib; Shehzad Basaria; Nader Rifai; Adrian S Dobs; Norma Kanarek; William G Nelson
Journal:  Clin Endocrinol (Oxf)       Date:  2011-08       Impact factor: 3.478

4.  Elevated high sensitivity C-reactive protein levels in aging men with low testosterone.

Authors:  Steven A Kaplan; Amy O Johnson-Levonas; Jianxin Lin; Arvind K Shah; Alan G Meehan
Journal:  Aging Male       Date:  2010-06       Impact factor: 5.892

5.  Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study.

Authors:  Harald Jörn Schneider; Caroline Sievers; Jens Klotsche; Steffen Böhler; David Pittrow; Hendrik Lehnert; Hans-Ulrich Wittchen; Günter Karl Stalla
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-08       Impact factor: 3.478

6.  Association of sex hormones and C-reactive protein levels in men.

Authors:  Varant Kupelian; Gretchen R Chiu; Andre B Araujo; Rachel E Williams; Richard V Clark; John B McKinlay
Journal:  Clin Endocrinol (Oxf)       Date:  2009-09-21       Impact factor: 3.478

7.  The effect of short-term estradiol therapy on clotting and inflammatory markers in older men receiving hormonal suppression therapy for prostate cancer.

Authors:  Pamela Taxel; Pooja Luthra; Pamela M Fall; Deborah Dauser
Journal:  Aging Male       Date:  2008-06       Impact factor: 5.892

8.  Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial.

Authors:  Hamid Reza Nakhai-Pour; Diederick E Grobbee; Marielle H Emmelot-Vonk; Michiel L Bots; Harald J J Verhaar; Yvonne T van der Schouw
Journal:  Am Heart J       Date:  2007-10-26       Impact factor: 4.749

9.  Serum testosterone level and related metabolic factors in men over 70 years old.

Authors:  Y-J Tang; W-J Lee; Y-T Chen; P-H Liu; M-C Lee; W H H Sheu
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256

10.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.

Authors:  Stephen Kaptoge; Emanuele Di Angelantonio; Gordon Lowe; Mark B Pepys; Simon G Thompson; Rory Collins; John Danesh
Journal:  Lancet       Date:  2009-12-22       Impact factor: 79.321

View more
  22 in total

1.  Endotoxin-initiated inflammation reduces testosterone production in men of reproductive age.

Authors:  Kelton Tremellen; Natalie McPhee; Karma Pearce; Sven Benson; Manfred Schedlowski; Harald Engler
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-11-28       Impact factor: 4.310

2.  Hypogonadism and the risk of rheumatic autoimmune disease.

Authors:  Jacques Baillargeon; Soham Al Snih; Mukaila A Raji; Randall J Urban; Gulshan Sharma; Melinda Sheffield-Moore; David S Lopez; Gwen Baillargeon; Yong-Fang Kuo
Journal:  Clin Rheumatol       Date:  2016-06-20       Impact factor: 2.980

3.  The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial.

Authors:  Susan Chadid; John R Barber; William G Nelson; Bora Gurel; M Scott Lucia; Ian M Thompson; Phyllis J Goodman; Frank Z Stanczyk; Howard L Parnes; Scott M Lippman; Angelo M De Marzo; Elizabeth A Platz
Journal:  Prostate       Date:  2020-06-07       Impact factor: 4.104

4.  High C-reactive protein is associated with increased risk of biochemical hypogonadism: a population-based cohort study.

Authors:  Amar Osmancevic; Kristin Ottarsdottir; Margareta Hellgren; Ulf Lindblad; Bledar Daka
Journal:  Endocr Connect       Date:  2022-06-24       Impact factor: 3.221

5.  Metabolic Changes in Androgen-Deprived Nondiabetic Men With Prostate Cancer Are Not Mediated by Cytokines or aP2.

Authors:  Thiago Gagliano-Jucá; M Furkan Burak; Karol M Pencina; Zhuoying Li; Robert R Edwards; Thomas G Travison; Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

Review 6.  Obesity and sex interact in the regulation of Alzheimer's disease.

Authors:  V Alexandra Moser; Christian J Pike
Journal:  Neurosci Biobehav Rev       Date:  2015-12-18       Impact factor: 8.989

7.  Effects of Testosterone on Benign and Malignant Conditions of the Prostate.

Authors:  Amin S Herati; Taylor P Kohn; Peter R Butler; Larry I Lipshultz
Journal:  Curr Sex Health Rep       Date:  2017-04-26

Review 8.  Testosterone replacement therapy and cardiovascular risk.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

9.  Testosterone-to-estradiol ratio and lung function in a prospective study of Puerto Rican youth.

Authors:  Yueh-Ying Han; Erick Forno; Selma F Witchel; Michelle L Manni; Edna Acosta-Pérez; Glorisa Canino; Juan C Celedón
Journal:  Ann Allergy Asthma Immunol       Date:  2021-04-20       Impact factor: 6.248

10.  Testosterone attenuates pulmonary epithelial inflammation in male rats of COPD model through preventing NRF1-derived NF-κB signaling.

Authors:  Xueting Wang; Linlin Huang; Shan Jiang; Kang Cheng; Dan Wang; Qianqian Luo; Xiaomei Wu; Li Zhu
Journal:  J Mol Cell Biol       Date:  2021-05-07       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.